P704 The biennial direct pharmaceutical costs per treatment with biologics for the inflammatory bowel disease in Greece: A comparative calculation study
ECCO'20 Vienna
2020
P705 Dietary practices and beliefs of patients with older-onset inflammatory bowel disease: A prospective UK study
ECCO'20 Vienna
2020
P706 Adalimumab drug levels at secondary loss of response in Crohn’s disease; are we aiming high enough? A retrospective, international multi-centre study
ECCO'20 Vienna
2020
P707 Anti-TNFα therapy has no effect on bone mineral density in younger patients with inflammatory bowel disease: A single-centre observational study
ECCO'20 Vienna
2020
P708 The effect of psychotherapy on quality of life in inflammatory bowel disease patients: A systematic literature review
ECCO'20 Vienna
2020
P709 Is azathioprine safe as long-term treatment in paediatric patients with inflammatory bowel disease?
ECCO'20 Vienna
2020
P710 The influence of probiotics to the efficacy of 5-ASA for the patients of ulcerative colitis
ECCO'20 Vienna
2020
P711 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to adalimumab in patients with Crohn’s disease
ECCO'20 Vienna
2020
P714 Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study
ECCO'20 Vienna
2020
P715 The prevalence of chronic musculoskeletal pain in patients with ulcerative colitis in comparison to control subjects: A cross-sectional study
ECCO'20 Vienna
2020
P716 Clinical significance of residual non-rectal inflammation in ulcerative colitis patients with clinical remission
ECCO'20 Vienna
2020
P717 Ustekinumab in Crohn’s disease: Real-world outcomes from the Sicilian Network for inflammatory bowel diseases (SN-IBD):–Preliminary results
ECCO'20 Vienna
2020
P718 Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn’s disease
ECCO'20 Vienna
2020
P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
ECCO'20 Vienna
2020
P720 Recurrent rectovaginal fistula in patients with Crohn’s disease: How can we improve the success rate of graciloplasty? A bi-centric European study in 30 patients
ECCO'20 Vienna
2020